These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 304673)

  • 21. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies].
    Kikuchi K
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Classification of acute leukemias by surface markers and correlation with the morphological diagnosis. Results of 111 cases].
    von Fliedner V; Carrel S; Morell A; Heumann D; Losa G; Hirt A; Jeannet M; Mach JP; Cruchaud A
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1524-6. PubMed ID: 6975992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of multiparameter studies of T-cell lymphoid neoplasms.
    Collins RD; Waldron JA; Glick AD
    Am J Clin Pathol; 1979 Oct; 72(4 Suppl):699-707. PubMed ID: 386780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B & T markers in leukemia and lymphoma.
    Bloomfield CD
    Minn Med; 1979 Jul; 62(7):499-501. PubMed ID: 315029
    [No Abstract]   [Full Text] [Related]  

  • 25. The immunologic approach to the pathology of malignant lymphomas.
    Lukes RJ
    Am J Clin Pathol; 1979 Oct; 72(4 Suppl):657-69. PubMed ID: 386777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
    Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical evaluation of hematologic malignancies.
    Miettinen M; Schwarting R; Hyun BH
    Hematol Oncol Clin North Am; 1994 Aug; 8(4):683-701. PubMed ID: 7961286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
    Howard DR; Eaves AC; Takei F
    Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Surface marker studies on lymphoma and leukemia cells with microcytotoxicity test using the UCLA Monoclonal Antibody Tray 5].
    Toki H; Okabe K; Kimura Y; Fujii M; Tamai M; Moriwaki S; Yamamoto Y
    Gan No Rinsho; 1985 Apr; 31(4):409-13. PubMed ID: 3874297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of a combined rosette-fluorescent test in studies on leukemia cells.
    Stella-Hołowiecka B; Hołowiecki J; Szeruda-Rudzka E; Krawczyk-Kuliś M
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):165-70. PubMed ID: 375866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunologic classification of non-Hodgkin's lymphomas: current status.
    Seligmann M; Brouet JC; Preud'homme JL
    Cancer Treat Rep; 1977 Sep; 61(6):1179-83. PubMed ID: 332351
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunological diagnosis of leukaemia and lymphoma: a World Health Organization/International Union of Immunological Societies technical report.
    Br J Haematol; 1978 Jan; 38(1):85-98. PubMed ID: 76475
    [No Abstract]   [Full Text] [Related]  

  • 33. Human lymphocyte differentiation markers and their application to immune deficiency and lymphoproliferative diseases.
    Siegal FP; Good RA
    Clin Haematol; 1977 Jun; 6(2):355-422. PubMed ID: 334421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of multiparameter studies of B-cell lymphomas.
    Taylor CR
    Am J Clin Pathol; 1979 Oct; 72(4 Suppl):687-98. PubMed ID: 386779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feline malignant lymphomas: comparison of morphologic and immunologic characteristics.
    Holmberg CA; Manning JS; Osburn BI
    Am J Vet Res; 1976 Dec; 37(12):1455-60. PubMed ID: 793460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment and characterization of BALB/c lymphoma lines with B cell properties.
    Kim KJ; Kanellopoulos-Langevin C; Merwin RM; Sachs DH; Asofsky R
    J Immunol; 1979 Feb; 122(2):549-54. PubMed ID: 310843
    [No Abstract]   [Full Text] [Related]  

  • 37. [Monoclonal antibodies IPO-4 recognizing antigen-activated human T and B lymphocytes].
    Sidorenko SP; Berdova AG; Vetrova EP; Shlapatskaia LN; Iurchenko OV; Evsev'eva AI; Gluzman DF
    Eksp Onkol; 1990; 12(3):21-4. PubMed ID: 2344819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-cell lymphomas and leukemias of post-thymic differentiation.
    Kadin ME; Said J
    Clin Lab Med; 1988 Mar; 8(1):135-50. PubMed ID: 2896086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of lymphocyte surface markers combined with the Lukes-Collins histologic classification in adult lymphoma.
    Bloomfield CD; Gajl-Peczalska KJ; Frizzera G; Kersey JH; Goldman AI
    N Engl J Med; 1979 Sep; 301(10):512-8. PubMed ID: 313510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunological classification of lymphoma and lymphocytic leukemias (author's transl)].
    Derre M; Tubiana N; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1999-2003. PubMed ID: 6256913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.